50 participants
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-07
- Start Date:
- 2026-06-15
- Completion:
- 2030-02-08
Conditions
- Nonsmall Cell Lung Cancer Stage III
Interventions
- DRUG
No Results Yet